Drug Type Small molecule drug |
Synonyms 7030B-C5 |
Target |
Action inhibitors |
Mechanism PCSK9 inhibitors(Proprotein convertase subtilisin kexin type 9 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H21N5O4 |
InChIKeyZIVVJVCKDAXYLK-UHFFFAOYSA-N |
CAS Registry370871-42-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Atherosclerosis | Preclinical | China | 01 Feb 2020 |





